An Open-Label, Comparative, Randomized, Prospective Study To Compare Sirolimus Versus Tacrolimus In De Novo Simultaneous Pancreas- Kidney Allograft Recipients Receiving An Induction Therapy With Antithymocyte Globulin Plus Mycophenolate Mofetil Plus Corticosteroids
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 04 May 2017
At a glance
- Drugs Sirolimus (Primary) ; Tacrolimus (Primary) ; Antithymocyte globulin; Corticosteroids; Mycophenolate mofetil
- Indications Kidney-pancreas transplant rejection
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 08 Sep 2013 Results presented at the 16th Congress of the European Society for Organ Transplantation.
- 21 May 2013 Results presented at the American Transplant Congress - 13th Joint Congress of the American Society of Transplant Surgeons and the American Society of Transplantation.